The Third First-in-Class Drug for ALS Approved for Clinical Trials | Building a Comprehensive Multi-Mechanism Treatment Matrix

May 19, 2025 – 4B Technologies' independently developed FIC drug candidate 4B02-01 injection has been approved for entering clinical trial by CDE

4B Technologies (Beijing) Co., Ltd was awarded the Certificate of Beijing Foreign-Funded R&D Center issued by the Beijing municipal Science & Technology Commission, Administrative Commission of Zhongguancun Science Park

On December 26, 2024, 4B Technologies (Beijing) Co., Ltd was awarded the Certificate of Beijing Foreign-Funded R&D Center issued by the Beijing municipal Science & Techno...

4B Technologies (Beijing) Co., Ltd was awarded the Certificate of Confirmations for Foreign Funded R&D Headquarters issued by the Beijing Municipal Commerce Bureau

On October 12, 2024, 4B Technologies (Beijing) Co., Ltd was awarded the Certificate of Confirmations for Foreign Funded R&D Headquarters issued by the Beijing Municipal C...